{"id":"placebo-first-24-weeks","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance administered in blinded clinical trials to establish a baseline for comparison against an active investigational drug. Any observed effects are attributed to natural disease progression, regression to the mean, or the placebo effect (psychological/expectation-driven response). In this Phase 3 trial context, placebo allows researchers to isolate the true efficacy of the investigational agent.","oneSentence":"Placebo has no active pharmacological mechanism; it serves as a control comparator in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:58.118Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT04199104","phase":"PHASE3","title":"A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-05","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":511},{"nctId":"NCT07494162","phase":"NA","title":"Imaging Metabolic and Perfusion Changes in Acupuncture Therapy for Myofascial Pain Syndrome","status":"NOT_YET_RECRUITING","sponsor":"University of California, Davis","startDate":"2026-04","conditions":"Myofascial Pain Syndrome (MPS), Chronic Low-back Pain (cLBP)","enrollment":64},{"nctId":"NCT03493178","phase":"EARLY_PHASE1","title":"Glutathione in Mild Cognitive Impairment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2018-04-19","conditions":"Mild Cognitive Impairment","enrollment":60},{"nctId":"NCT04472598","phase":"PHASE3","title":"Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis","status":"COMPLETED","sponsor":"AbbVie","startDate":"2020-09-29","conditions":"Myelofibrosis (MF)","enrollment":252},{"nctId":"NCT05529927","phase":"PHASE2","title":"Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Parnassia Addiction Research Centre","startDate":"2026-05","conditions":"Cocaine Use Disorder","enrollment":204},{"nctId":"NCT06726265","phase":"PHASE3","title":"Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Immutep S.A.S.","startDate":"2025-03-21","conditions":"Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)","enrollment":756},{"nctId":"NCT07447063","phase":"PHASE4","title":"The Impact of Dietary Salt on the Severity of Eczema","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-03-06","conditions":"Eczema, Atopic Dermatitis","enrollment":40},{"nctId":"NCT07477782","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05","conditions":"Primary Sclerosing Cholangitis (PSC), Inflammatory Bowel Disease (IBD)","enrollment":72},{"nctId":"NCT05634876","phase":"PHASE1","title":"UB-312 in Patients With Synucleinopathies","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2023-05-31","conditions":"Multiple System Atrophy, Parkinson Disease","enrollment":8},{"nctId":"NCT05523323","phase":"PHASE3","title":"A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010/LEAP-010)-China Extension","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-10-30","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":112},{"nctId":"NCT06708299","phase":"PHASE3","title":"CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)","status":"RECRUITING","sponsor":"Cardiol Therapeutics Inc.","startDate":"2025-04-07","conditions":"Recurrent Pericarditis","enrollment":110},{"nctId":"NCT05379634","phase":"PHASE2","title":"A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-07-05","conditions":"Myositis","enrollment":36},{"nctId":"NCT03953300","phase":"PHASE4","title":"Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2019-10-08","conditions":"Asthma","enrollment":75},{"nctId":"NCT07103746","phase":"PHASE2","title":"Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-02-26","conditions":"Autoimmune Disorders","enrollment":30},{"nctId":"NCT06372249","phase":"PHASE2","title":"A Clinical Trial of Soluble Fiber for Asthma","status":"RECRUITING","sponsor":"Phoenix Children's Hospital","startDate":"2025-11-10","conditions":"Asthma in Children","enrollment":105},{"nctId":"NCT03644667","phase":"PHASE2","title":"Tocilizumab in Cardiac Transplantation","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-12-20","conditions":"Heart Transplant","enrollment":385},{"nctId":"NCT06516302","phase":"PHASE3","title":"A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps","status":"ACTIVE_NOT_RECRUITING","sponsor":"Genrix (Shanghai) Biopharmaceutical Co., Ltd.","startDate":"2024-09-19","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":228},{"nctId":"NCT05144256","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period","status":"ACTIVE_NOT_RECRUITING","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2022-06-08","conditions":"Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia","enrollment":49},{"nctId":"NCT05649748","phase":"PHASE2, PHASE3","title":"An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Insmed Incorporated","startDate":"2023-03-07","conditions":"Pulmonary Arterial Hypertension","enrollment":91},{"nctId":"NCT05152810","phase":"NA","title":"Effectiveness of Transcranial Magnetic Stimulation (TMS) in Smoking Cessation, Combining Withdrawal Stimulation Followed by Maintenance Stimulation to Prevent Relapse","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2022-01-06","conditions":"Smoking Cessation","enrollment":88},{"nctId":"NCT03725202","phase":"PHASE3","title":"A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis","status":"COMPLETED","sponsor":"AbbVie","startDate":"2019-01-24","conditions":"Giant Cell Arteritis (GCA)","enrollment":429},{"nctId":"NCT04035005","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2019-08-12","conditions":"Multiple Sclerosis, Primary Progressive","enrollment":1013},{"nctId":"NCT04157335","phase":"PHASE3","title":"Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2019-11-25","conditions":"Nasal Polyposis, Eosinophilic Chronic Rhinosinusitis","enrollment":295},{"nctId":"NCT07377136","phase":"NA","title":"Influence of the Urolithin A on the Population With BMI Higher Than 30 During Restricted Eating.","status":"ENROLLING_BY_INVITATION","sponsor":"Charles University, Czech Republic","startDate":"2025-10-08","conditions":"Obesity & Overweight","enrollment":100},{"nctId":"NCT04903002","phase":"PHASE2, PHASE3","title":"Evaluating the Efficacy of Intranasal Oxytocin on Chronic Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial University of Newfoundland","startDate":"2022-04-01","conditions":"Chronic Pain","enrollment":336},{"nctId":"NCT07235683","phase":"PHASE4","title":"Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-12-24","conditions":"CMV, Lung Transplant Recipient","enrollment":40},{"nctId":"NCT02162849","phase":"PHASE4","title":"Reward Sensitivity and Pharmacotherapy for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Tobacco Use Cessation","enrollment":204},{"nctId":"NCT04918147","phase":"PHASE2","title":"Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-10-13","conditions":"IgG4 Related Disease, IgG4-RD","enrollment":8},{"nctId":"NCT05123703","phase":"PHASE3","title":"A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-05-19","conditions":"Relapsing-Remitting Multiple Sclerosis","enrollment":188},{"nctId":"NCT03412747","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2018-01-26","conditions":"Chronic Plaque Psoriasis, Moderate to Severe Plaque Psoriasis","enrollment":478},{"nctId":"NCT07163650","phase":"PHASE4","title":"Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery","status":"RECRUITING","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2025-09-16","conditions":"Obesity, Weight Loss, Metabolic Surgery","enrollment":60},{"nctId":"NCT04564339","phase":"PHASE2","title":"Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)","status":"TERMINATED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2021-01-19","conditions":"Lupus Nephritis, Immunoglobulin A Nephropathy","enrollment":123},{"nctId":"NCT06194825","phase":"PHASE3","title":"EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid Cardiomyopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2023-12-01","conditions":"Transthyretin Amyloid Cardiomyopathy","enrollment":64},{"nctId":"NCT07346989","phase":"NA","title":"Non-invasive Brain Stimulation on Functional Capacity in Prefrail Older Adults","status":"NOT_YET_RECRUITING","sponsor":"University of Valencia","startDate":"2026-01","conditions":"Prefrail Elderly","enrollment":120},{"nctId":"NCT05704738","phase":"PHASE3","title":"A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)","status":"COMPLETED","sponsor":"Amgen","startDate":"2023-04-20","conditions":"Atopic Dermatitis","enrollment":532},{"nctId":"NCT07337096","phase":"NA","title":"Electro-Acupuncture in Lung cancER : EALER Study","status":"NOT_YET_RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2026-01","conditions":"Non Small Cell Lung Cancer, Accupuncture, PD-1 Inhibitors","enrollment":424},{"nctId":"NCT05569759","phase":"PHASE2","title":"A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)","status":"COMPLETED","sponsor":"Kezar Life Sciences, Inc.","startDate":"2023-05-23","conditions":"Autoimmune Hepatitis","enrollment":24},{"nctId":"NCT03727022","phase":"PHASE2","title":"Safety and Bone Health Study of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis","status":"COMPLETED","sponsor":"Biosplice Therapeutics, Inc.","startDate":"2018-11-28","conditions":"Knee Osteoarthritis","enrollment":101},{"nctId":"NCT03199885","phase":"PHASE3","title":"Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2019-04-05","conditions":"Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma","enrollment":190},{"nctId":"NCT05559671","phase":"PHASE4","title":"Safety of the Herpes Zoster Subunit Vaccine in Lupus","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2023-12-21","conditions":"Systemic Lupus Erythematosus","enrollment":224},{"nctId":"NCT05838573","phase":"PHASE3","title":"Metformin Treatment on Cognitive Impairment of Schizophrenia","status":"RECRUITING","sponsor":"Central South University","startDate":"2023-05-08","conditions":"Schizophrenia","enrollment":120},{"nctId":"NCT07091175","phase":"PHASE2","title":"Dupilumab Therapy in Nephrotic Syndrome in Children","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-11-27","conditions":"Nephrotic Syndrome in Children, Nephrotic Syndrome Steroid-Dependent","enrollment":66},{"nctId":"NCT02299440","phase":"PHASE3","title":"Effects of Ketamine in the Acute Phase of Suicidal Ideation","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2015-04","conditions":"Suicidal Ideation","enrollment":156},{"nctId":"NCT05498181","phase":"PHASE2","title":"Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2022-10-11","conditions":"Hemodialysis","enrollment":100},{"nctId":"NCT05388656","phase":"PHASE4","title":"Estrogen Variability and Irritability During the Menopause Transition","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-06-15","conditions":"Menopause, Irritable Mood","enrollment":40},{"nctId":"NCT04713657","phase":"PHASE1","title":"Beta-blocker Administration for Cardiomyocyte Division","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2022-12-16","conditions":"Tetralogy of Fallot, Double Outlet Right Ventricle","enrollment":40},{"nctId":"NCT04844970","phase":"PHASE2","title":"Anamorelin Study for Advanced Pancreatic Cancer","status":"TERMINATED","sponsor":"Lahey Clinic","startDate":"2023-04-01","conditions":"Metastatic Pancreatic Cancer","enrollment":4},{"nctId":"NCT06364228","phase":"PHASE2","title":"Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia","status":"RECRUITING","sponsor":"University of Nebraska","startDate":"2026-01-05","conditions":"Stress","enrollment":32},{"nctId":"NCT06327152","phase":"PHASE2","title":"Caffeine Use in the Management of Preterm Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Irvine","startDate":"2024-02-22","conditions":"Apnea of Prematurity","enrollment":80},{"nctId":"NCT06121375","phase":"PHASE2, PHASE3","title":"Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy","status":"TERMINATED","sponsor":"Intercept Pharmaceuticals","startDate":"2024-09-02","conditions":"Biliary Atresia","enrollment":28},{"nctId":"NCT05421598","phase":"PHASE2","title":"Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma","status":"COMPLETED","sponsor":"Sanofi","startDate":"2022-06-30","conditions":"Asthma","enrollment":446},{"nctId":"NCT02018692","phase":"PHASE1, PHASE2","title":"The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa","status":"NOT_YET_RECRUITING","sponsor":"Sheba Medical Center","startDate":"2026-03-01","conditions":"Retinitis Pigmentosa","enrollment":30},{"nctId":"NCT05459298","phase":"NA","title":"ViDES Trial (Vitamin D Extra Supplementation)","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-09-06","conditions":"Vitamin D Deficiency","enrollment":180},{"nctId":"NCT04435288","phase":"PHASE3","title":"Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2020-08-24","conditions":"Peripheral Spondyloarthritis","enrollment":90},{"nctId":"NCT06493578","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vyne Therapeutics Inc.","startDate":"2024-06-04","conditions":"Non-segmental Vitiligo","enrollment":200},{"nctId":"NCT03881696","phase":"PHASE3","title":"Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-07-22","conditions":"Peanut Allergy, Multi-food Allergy","enrollment":471},{"nctId":"NCT06053814","phase":"PHASE1, PHASE2","title":"NS-050/NCNP-03 in Boys With DMD (Meteor50)","status":"RECRUITING","sponsor":"NS Pharma, Inc.","startDate":"2024-09-18","conditions":"Duchenne Muscular Dystrophy","enrollment":20},{"nctId":"NCT05306873","phase":"PHASE2","title":"Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-11-30","conditions":"Systemic Lupus Erythematosus","enrollment":12},{"nctId":"NCT03977207","phase":"NA","title":"A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2020-07-20","conditions":"Thyroid; Functional Disturbance, Hypothyroidism, Hemodialysis","enrollment":336},{"nctId":"NCT06015022","phase":"PHASE2","title":"EGCG for Hepatocellular Carcinoma Chemoprevention","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-09-01","conditions":"Cirrhosis, Liver","enrollment":60},{"nctId":"NCT05330455","phase":"PHASE1, PHASE2","title":"Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2022-04-14","conditions":"Hepatitis B","enrollment":74},{"nctId":"NCT07118696","phase":"PHASE3","title":"Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease","status":"NOT_YET_RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2026-02-01","conditions":"Pulmonary TB","enrollment":1000},{"nctId":"NCT06506136","phase":"PHASE1, PHASE2","title":"Evaluation of Fluoxetine for Refractory Constipation With Somatic Symptom Disorder Features","status":"NOT_YET_RECRUITING","sponsor":"Zhifeng Zhao, PhD","startDate":"2025-09-01","conditions":"Refractory Constipation, Somatic Symptom Disorder (DSM-5), Functional Constipation (FC)","enrollment":194},{"nctId":"NCT07090343","phase":"PHASE3","title":"Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement","status":"NOT_YET_RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2026-04-01","conditions":"Aortic Stenosis, Heart Failure","enrollment":826},{"nctId":"NCT04007393","phase":"PHASE2","title":"SMART Use of Medication for the Treatment of Adolescent Severe Obesity","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2019-11-21","conditions":"Adolescent Obesity","enrollment":150},{"nctId":"NCT04888221","phase":"PHASE3","title":"Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-09-24","conditions":"Giant Cell Arteritis, Neurovascular Disorder","enrollment":66},{"nctId":"NCT07014631","phase":"PHASE2","title":"Phase II Dose-Finding of Oral SSS17 for Anemia in Non-Dialysis CKD","status":"COMPLETED","sponsor":"Shenyang Sunshine Pharmaceutical Co., LTD.","startDate":"2023-03-01","conditions":"Anemia in Pre-Dialysis Patients","enrollment":86},{"nctId":"NCT02446652","phase":"PHASE3","title":"Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer","status":"WITHDRAWN","sponsor":"National Institute of Cancerología","startDate":"2015-01-01","conditions":"Cervical Cancer","enrollment":""},{"nctId":"NCT05496543","phase":"NA","title":"Acupuncture for Functional Constipation in Older Adults","status":"COMPLETED","sponsor":"Yin Ping","startDate":"2022-10-10","conditions":"Constipation - Functional","enrollment":84},{"nctId":"NCT02975349","phase":"PHASE2","title":"A Study of Efficacy and Safety of M2951 in Participants With Relapsing Multiple Sclerosis","status":"TERMINATED","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2017-03-07","conditions":"Relapsing-remitting Multiple Sclerosis","enrollment":267},{"nctId":"NCT06778473","phase":"NA","title":"Intradermal Acupuncture and Self-rehabilitation Program in Patients With Severe Bell's Palsy","status":"RECRUITING","sponsor":"Zhangjiagang First People's Hospital","startDate":"2025-03-24","conditions":"Bell Palsy","enrollment":552},{"nctId":"NCT02981979","phase":"NA","title":"Takayasu Arteritis Clinical Trial in China","status":"COMPLETED","sponsor":"Jiang lindi","startDate":"2016-12-22","conditions":"Takayasu Arteritis","enrollment":116},{"nctId":"NCT05879406","phase":"NA","title":"A Study to Evaluate the Efficacy and Safety of Clear Skin Formula on Mitigating Mild to Moderate Non-cystic Acne","status":"COMPLETED","sponsor":"Ablon Skin Institute Research Center","startDate":"2023-05-31","conditions":"Non-Cystic Acne","enrollment":40},{"nctId":"NCT04621383","phase":"NA","title":"Effects of Whey Protein Supplementation Collagen Associated to Resistance Training in Older Woman","status":"COMPLETED","sponsor":"Universidade Estadual de Londrina","startDate":"2019-05-27","conditions":"Sarcopenia, Collagen Degeneration","enrollment":67},{"nctId":"NCT03306979","phase":"PHASE2","title":"Memory and Antioxidants in Vascular Impairment Trial","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2018-04-30","conditions":"Vascular Cognitive Impairment no Dementia","enrollment":60},{"nctId":"NCT06886620","phase":"PHASE3","title":"Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent Claudication","status":"TERMINATED","sponsor":"Genovate Biotechnology Co., Ltd.,","startDate":"2016-03-14","conditions":"Intermittent Claudication","enrollment":14},{"nctId":"NCT06881628","phase":"PHASE4","title":"Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients","status":"RECRUITING","sponsor":"Tanta University","startDate":"2024-12-02","conditions":"Upper Gastrointestinal Bleeding (UGIB), Variceal Bleeding, Cirrhosis","enrollment":194},{"nctId":"NCT05325645","phase":"PHASE3","title":"Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia","status":"RECRUITING","sponsor":"Otsuka Pharmaceutical Co., Ltd.","startDate":"2022-07-21","conditions":"Acute Schizophrenia","enrollment":450},{"nctId":"NCT03779048","phase":"PHASE4","title":"Use of Medication to Improve Weight Loss in Suboptimal Early Responders to Behavioral Treatment","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2019-07-15","conditions":"Obesity","enrollment":147},{"nctId":"NCT05312008","phase":"PHASE2","title":"Does Oxytocin Alter Tolerance to or Motivation for Alcohol","status":"TERMINATED","sponsor":"Indiana University","startDate":"2022-01-16","conditions":"Alcohol Use Disorder","enrollment":6},{"nctId":"NCT04963270","phase":"PHASE3","title":"A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis","status":"TERMINATED","sponsor":"Hoffmann-La Roche","startDate":"2021-10-19","conditions":"Generalized Myasthenia Gravis","enrollment":188},{"nctId":"NCT05457959","phase":"PHASE1","title":"Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant","status":"WITHDRAWN","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2024-12-01","conditions":"Diffuse Hemispheric Glioma, H3 G34-Mutant","enrollment":""},{"nctId":"NCT05913752","phase":"PHASE1, PHASE2","title":"A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects","status":"NOT_YET_RECRUITING","sponsor":"Clearmind Medicine Inc.","startDate":"2025-03-31","conditions":"Alcohol Use Disorder","enrollment":84},{"nctId":"NCT03461276","phase":"PHASE2","title":"Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD","status":"COMPLETED","sponsor":"Araclon Biotech S.L.","startDate":"2017-12-13","conditions":"Mild Cognitive Impairment, Alzheimer Disease","enrollment":134},{"nctId":"NCT05979831","phase":"PHASE1, PHASE2","title":"A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome","status":"TERMINATED","sponsor":"Daiichi Sankyo","startDate":"2023-09-28","conditions":"Netherton Syndrome","enrollment":9},{"nctId":"NCT06189495","phase":"PHASE2","title":"A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease","status":"RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-12-30","conditions":"Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD), Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)","enrollment":30},{"nctId":"NCT02465268","phase":"PHASE2","title":"Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme","status":"COMPLETED","sponsor":"University of Florida","startDate":"2016-08-09","conditions":"Glioblastoma Multiforme, Glioblastoma, Malignant Glioma","enrollment":175},{"nctId":"NCT06449287","phase":"NA","title":"Impact of Exogenous Ketones on Indices of Keto-Adaptation in Obese Subjects on Weight Reducing Diets.","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2018-07-05","conditions":"Ketogenic Diet, Weight Loss","enrollment":37},{"nctId":"NCT04322929","phase":"PHASE2","title":"Roflumilast in Non-CF Bronchiectasis Study (2019)","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2020-11-12","conditions":"Non-cystic Fibrosis Bronchiectasis","enrollment":42},{"nctId":"NCT04872218","phase":"PHASE2","title":"Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy","status":"COMPLETED","sponsor":"Philippe Bégin","startDate":"2022-03-01","conditions":"Peanut Allergy","enrollment":14},{"nctId":"NCT05786469","phase":"PHASE3","title":"Patiromer Trial in CKD Stage IIIB to V","status":"TERMINATED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2023-08-02","conditions":"Hyperkalemia","enrollment":2},{"nctId":"NCT04200755","phase":"PHASE2","title":"Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2020-05-19","conditions":"Localized Scleroderma","enrollment":45},{"nctId":"NCT01767090","phase":"PHASE2","title":"A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain","status":"COMPLETED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2012-12-04","conditions":"Endometriosis","enrollment":912},{"nctId":"NCT03747939","phase":"PHASE4","title":"Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.","status":"COMPLETED","sponsor":"Amgen","startDate":"2018-12-31","conditions":"Arthritis, Psoriatic","enrollment":310},{"nctId":"NCT03384784","phase":"PHASE2","title":"Effect of Galantamine on Inflammation and Cognition","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2017-10-30","conditions":"HIV Associated Cognitive Motor Complex","enrollment":63},{"nctId":"NCT04877457","phase":"PHASE4","title":"Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.","status":"TERMINATED","sponsor":"Yale University","startDate":"2022-02-15","conditions":"Radiologically Isolated Syndrome, Multiple Sclerosis","enrollment":3},{"nctId":"NCT03016013","phase":"PHASE3","title":"A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects with Inadequate Response to MTX Due to Treat Moderate and Severe Rheumatoid Arthritis.","status":"COMPLETED","sponsor":"RemeGen Co., Ltd.","startDate":"2017-03-29","conditions":"Moderate and Severe RheumatoId Arthritis","enrollment":479},{"nctId":"NCT06504420","phase":"PHASE2","title":"The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control Study","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-10-15","conditions":"Primary Antiphospholipid Syndrome","enrollment":70},{"nctId":"NCT04543942","phase":"NA","title":"Sex Differences in Risk for Alcohol Abuse","status":"COMPLETED","sponsor":"Mark Fillmore","startDate":"2019-11-01","conditions":"Alcohol Abuse","enrollment":28},{"nctId":"NCT03735420","phase":"PHASE1","title":"Xanthohumol Metabolism and Signature","status":"ACTIVE_NOT_RECRUITING","sponsor":"National University of Natural Medicine","startDate":"2019-08-12","conditions":"Healthy","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":51,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo - first 24 weeks","genericName":"Placebo - first 24 weeks","companyName":"University of Alabama at Birmingham","companyId":"university-of-alabama-at-birmingham","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo is a treatment that has been studied in various clinical trials for conditions such as smoking cessation, non-cystic fibrosis bronchiectasis, hyperkalemia, myelodysplastic syndromes, and psoriasis. Placebo has been used in conjunction with transcranial magnetic stimulation (TMS) sessions, evaluations, and CMS (no further information available) in these trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}